ID   DPYS_HUMAN              Reviewed;         519 AA.
AC   Q14117;
DT   15-JUL-1998, integrated into UniProtKB/Swiss-Prot.
DT   01-NOV-1996, sequence version 1.
DT   22-JUL-2015, entry version 139.
DE   RecName: Full=Dihydropyrimidinase;
DE            Short=DHP;
DE            Short=DHPase;
DE            EC=3.5.2.2;
DE   AltName: Full=Dihydropyrimidine amidohydrolase;
DE   AltName: Full=Hydantoinase;
GN   Name=DPYS;
OS   Homo sapiens (Human).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi;
OC   Mammalia; Eutheria; Euarchontoglires; Primates; Haplorrhini;
OC   Catarrhini; Hominidae; Homo.
OX   NCBI_TaxID=9606;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [MRNA].
RC   TISSUE=Liver;
RX   PubMed=8973361; DOI=10.1016/S0378-1119(96)00445-3;
RA   Hamajima N., Matsuda K., Sakata S., Tamaki N., Sasaki M., Nonaka M.;
RT   "A novel gene family defined by human dihydropyrimidinase and three
RT   related proteins with differential tissue distribution.";
RL   Gene 180:157-163(1996).
RN   [2]
RP   NUCLEOTIDE SEQUENCE [GENOMIC DNA], AND VARIANTS DHPD ARG-68; ARG-334;
RP   ARG-360; ARG-435 AND THR-490.
RX   PubMed=9718352; DOI=10.1086/302022;
RA   Hamajima N., Kouwaki M., Vreken P., Matsuda K., Sumi S., Imaeda M.,
RA   Ohba S., Kidouchi K., Nonaka M., Sasaki M., Tamaki N., Endo Y.,
RA   de Abreu R., Rottevell J., van Kuilenburg A., van Gennip A.,
RA   Togari H., Wada Y.;
RT   "Dihydropyrimidinase deficiency: structural organization, chromosomal
RT   localization, and mutation analysis of the human dihydropyrimidinase
RT   gene.";
RL   Am. J. Hum. Genet. 63:717-726(1998).
RN   [3]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA].
RC   TISSUE=Colon, Kidney, and Stomach;
RX   PubMed=15489334; DOI=10.1101/gr.2596504;
RG   The MGC Project Team;
RT   "The status, quality, and expansion of the NIH full-length cDNA
RT   project: the Mammalian Gene Collection (MGC).";
RL   Genome Res. 14:2121-2127(2004).
RN   [4]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-79, AND IDENTIFICATION
RP   BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Liver;
RX   PubMed=24275569; DOI=10.1016/j.jprot.2013.11.014;
RA   Bian Y., Song C., Cheng K., Dong M., Wang F., Huang J., Sun D.,
RA   Wang L., Ye M., Zou H.;
RT   "An enzyme assisted RP-RPLC approach for in-depth analysis of human
RT   liver phosphoproteome.";
RL   J. Proteomics 96:253-262(2014).
RN   [5]
RP   X-RAY CRYSTALLOGRAPHY (2.80 ANGSTROMS) IN COMPLEX WITH ZINC IONS, AND
RP   COFACTOR.
RG   Structural genomics consortium (SGC);
RT   "The crystal structure of human dihydropyrimidinase.";
RL   Submitted (FEB-2009) to the PDB data bank.
CC   -!- FUNCTION: Catalyzes the second step of the reductive pyrimidine
CC       degradation, the reversible hydrolytic ring opening of
CC       dihydropyrimidines. Can catalyze the ring opening of 5,6-
CC       dihydrouracil to N-carbamyl-alanine and of 5,6-dihydrothymine to
CC       N-carbamyl-amino isobutyrate.
CC   -!- CATALYTIC ACTIVITY: 5,6-dihydrouracil + H(2)O = 3-
CC       ureidopropanoate.
CC   -!- COFACTOR:
CC       Name=Zn(2+); Xref=ChEBI:CHEBI:29105; Evidence={ECO:0000269|Ref.5};
CC       Note=Binds 2 Zn(2+) ions per subunit. {ECO:0000269|Ref.5};
CC   -!- SUBUNIT: Homotetramer. {ECO:0000305|Ref.5}.
CC   -!- TISSUE SPECIFICITY: Liver and kidney.
CC   -!- PTM: Carbamylation allows a single lysine to coordinate two zinc
CC       ions. {ECO:0000250}.
CC   -!- DISEASE: Dihydropyrimidinase deficiency (DHPD) [MIM:222748]: A
CC       disorder characterized by dihydropyrimidinuria and associated with
CC       a variable clinical phenotype characterized by epileptic or
CC       convulsive attacks, dysmorphic features and severe developmental
CC       delay, and congenital microvillous atrophy.
CC       {ECO:0000269|PubMed:9718352}. Note=The disease is caused by
CC       mutations affecting the gene represented in this entry.
CC   -!- SIMILARITY: Belongs to the DHOase family.
CC       Hydantoinase/dihydropyrimidinase subfamily. {ECO:0000305}.
CC   -----------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see http://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution-NoDerivs License
CC   -----------------------------------------------------------------------
DR   EMBL; D78011; BAA11189.1; -; mRNA.
DR   EMBL; AB004678; BAA33067.1; -; Genomic_DNA.
DR   EMBL; BC034395; AAH34395.1; -; mRNA.
DR   CCDS; CCDS6302.1; -.
DR   PIR; JC5315; JC5315.
DR   RefSeq; NP_001376.1; NM_001385.2.
DR   UniGene; Hs.443161; -.
DR   PDB; 2VR2; X-ray; 2.80 A; A=1-519.
DR   PDBsum; 2VR2; -.
DR   ProteinModelPortal; Q14117; -.
DR   SMR; Q14117; 5-493.
DR   BioGrid; 108141; 3.
DR   STRING; 9606.ENSP00000276651; -.
DR   MEROPS; M38.973; -.
DR   PhosphoSite; Q14117; -.
DR   BioMuta; DPYS; -.
DR   DMDM; 3122049; -.
DR   PaxDb; Q14117; -.
DR   PRIDE; Q14117; -.
DR   DNASU; 1807; -.
DR   Ensembl; ENST00000351513; ENSP00000276651; ENSG00000147647.
DR   GeneID; 1807; -.
DR   KEGG; hsa:1807; -.
DR   UCSC; uc003yly.4; human.
DR   CTD; 1807; -.
DR   GeneCards; GC08M105391; -.
DR   HGNC; HGNC:3013; DPYS.
DR   HPA; HPA024785; -.
DR   MIM; 222748; phenotype.
DR   MIM; 613326; gene.
DR   neXtProt; NX_Q14117; -.
DR   Orphanet; 38874; Dihydropyrimidinuria.
DR   PharmGKB; PA146; -.
DR   eggNOG; COG0044; -.
DR   GeneTree; ENSGT00760000119241; -.
DR   HOGENOM; HOG000219145; -.
DR   HOVERGEN; HBG000806; -.
DR   InParanoid; Q14117; -.
DR   KO; K01464; -.
DR   OMA; PDWDHAA; -.
DR   OrthoDB; EOG7SJD48; -.
DR   PhylomeDB; Q14117; -.
DR   TreeFam; TF314706; -.
DR   Reactome; REACT_1023; Pyrimidine catabolism.
DR   EvolutionaryTrace; Q14117; -.
DR   GeneWiki; DPYS; -.
DR   GenomeRNAi; 1807; -.
DR   NextBio; 7365; -.
DR   PRO; PR:Q14117; -.
DR   Proteomes; UP000005640; Chromosome 8.
DR   Bgee; Q14117; -.
DR   CleanEx; HS_DPYS; -.
DR   ExpressionAtlas; Q14117; baseline and differential.
DR   Genevisible; Q14117; HS.
DR   GO; GO:0005829; C:cytosol; ISS:UniProtKB.
DR   GO; GO:0070062; C:extracellular exosome; IDA:UniProtKB.
DR   GO; GO:0016597; F:amino acid binding; IEA:Ensembl.
DR   GO; GO:0004157; F:dihydropyrimidinase activity; IDA:UniProtKB.
DR   GO; GO:0002059; F:thymine binding; IEA:Ensembl.
DR   GO; GO:0002058; F:uracil binding; IEA:Ensembl.
DR   GO; GO:0008270; F:zinc ion binding; NAS:UniProtKB.
DR   GO; GO:0019482; P:beta-alanine metabolic process; IEA:Ensembl.
DR   GO; GO:0055086; P:nucleobase-containing small molecule metabolic process; TAS:Reactome.
DR   GO; GO:0051289; P:protein homotetramerization; ISS:UniProtKB.
DR   GO; GO:0006208; P:pyrimidine nucleobase catabolic process; IDA:UniProtKB.
DR   GO; GO:0006206; P:pyrimidine nucleobase metabolic process; TAS:Reactome.
DR   GO; GO:0046135; P:pyrimidine nucleoside catabolic process; TAS:Reactome.
DR   GO; GO:0044281; P:small molecule metabolic process; TAS:Reactome.
DR   GO; GO:0006210; P:thymine catabolic process; ISS:UniProtKB.
DR   GO; GO:0006212; P:uracil catabolic process; IDA:UniProtKB.
DR   Gene3D; 2.30.40.10; -; 2.
DR   InterPro; IPR006680; Amidohydro_1.
DR   InterPro; IPR030633; Dihydropyrimidinase.
DR   InterPro; IPR011778; Hydantoinase/dihydroPyrase.
DR   InterPro; IPR011059; Metal-dep_hydrolase_composite.
DR   PANTHER; PTHR11647:SF50; PTHR11647:SF50; 1.
DR   Pfam; PF01979; Amidohydro_1; 1.
DR   SUPFAM; SSF51338; SSF51338; 2.
DR   TIGRFAMs; TIGR02033; D-hydantoinase; 1.
PE   1: Evidence at protein level;
KW   3D-structure; Complete proteome; Disease mutation; Hydrolase;
KW   Metal-binding; Phosphoprotein; Reference proteome; Zinc.
FT   CHAIN         1    519       Dihydropyrimidinase.
FT                                /FTId=PRO_0000165906.
FT   METAL        67     67       Zinc 1.
FT   METAL        69     69       Zinc 1.
FT   METAL       159    159       Zinc 1; via carbamate group.
FT   METAL       159    159       Zinc 2; via carbamate group.
FT   METAL       192    192       Zinc 2.
FT   METAL       248    248       Zinc 2.
FT   METAL       326    326       Zinc 1.
FT   BINDING     164    164       Substrate. {ECO:0000250}.
FT   BINDING     347    347       Substrate; via carbonyl oxygen.
FT                                {ECO:0000250}.
FT   MOD_RES      79     79       Phosphoserine.
FT                                {ECO:0000269|PubMed:24275569}.
FT   MOD_RES     159    159       N6-carboxylysine. {ECO:0000250}.
FT   MOD_RES     256    256       N6-succinyllysine.
FT                                {ECO:0000250|UniProtKB:Q9EQF5}.
FT   VARIANT      68     68       T -> R (in DHPD).
FT                                {ECO:0000269|PubMed:9718352}.
FT                                /FTId=VAR_002267.
FT   VARIANT     334    334       Q -> R (in DHPD; dbSNP:rs121964923).
FT                                {ECO:0000269|PubMed:9718352}.
FT                                /FTId=VAR_002268.
FT   VARIANT     360    360       W -> R (in DHPD; dbSNP:rs121964924).
FT                                {ECO:0000269|PubMed:9718352}.
FT                                /FTId=VAR_002269.
FT   VARIANT     435    435       G -> R (in DHPD).
FT                                {ECO:0000269|PubMed:9718352}.
FT                                /FTId=VAR_002270.
FT   VARIANT     490    490       R -> T (in DHPD).
FT                                {ECO:0000269|PubMed:9718352}.
FT                                /FTId=VAR_002271.
FT   STRAND        6     11       {ECO:0000244|PDB:2VR2}.
FT   STRAND       13     15       {ECO:0000244|PDB:2VR2}.
FT   STRAND       20     22       {ECO:0000244|PDB:2VR2}.
FT   STRAND       24     28       {ECO:0000244|PDB:2VR2}.
FT   STRAND       31     36       {ECO:0000244|PDB:2VR2}.
FT   STRAND       50     53       {ECO:0000244|PDB:2VR2}.
FT   STRAND       57     61       {ECO:0000244|PDB:2VR2}.
FT   STRAND       63     68       {ECO:0000244|PDB:2VR2}.
FT   STRAND       75     78       {ECO:0000244|PDB:2VR2}.
FT   HELIX        85     91       {ECO:0000244|PDB:2VR2}.
FT   TURN         92     94       {ECO:0000244|PDB:2VR2}.
FT   STRAND       95    102       {ECO:0000244|PDB:2VR2}.
FT   HELIX       110    121       {ECO:0000244|PDB:2VR2}.
FT   TURN        122    124       {ECO:0000244|PDB:2VR2}.
FT   STRAND      126    135       {ECO:0000244|PDB:2VR2}.
FT   HELIX       140    151       {ECO:0000244|PDB:2VR2}.
FT   STRAND      157    164       {ECO:0000244|PDB:2VR2}.
FT   TURN        165    168       {ECO:0000244|PDB:2VR2}.
FT   HELIX       172    185       {ECO:0000244|PDB:2VR2}.
FT   STRAND      188    192       {ECO:0000244|PDB:2VR2}.
FT   HELIX       196    208       {ECO:0000244|PDB:2VR2}.
FT   HELIX       215    219       {ECO:0000244|PDB:2VR2}.
FT   HELIX       223    240       {ECO:0000244|PDB:2VR2}.
FT   STRAND      244    249       {ECO:0000244|PDB:2VR2}.
FT   HELIX       252    263       {ECO:0000244|PDB:2VR2}.
FT   STRAND      268    273       {ECO:0000244|PDB:2VR2}.
FT   HELIX       274    278       {ECO:0000244|PDB:2VR2}.
FT   HELIX       282    285       {ECO:0000244|PDB:2VR2}.
FT   HELIX       289    293       {ECO:0000244|PDB:2VR2}.
FT   HELIX       307    316       {ECO:0000244|PDB:2VR2}.
FT   HELIX       332    335       {ECO:0000244|PDB:2VR2}.
FT   HELIX       336    338       {ECO:0000244|PDB:2VR2}.
FT   HELIX       342    344       {ECO:0000244|PDB:2VR2}.
FT   TURN        352    354       {ECO:0000244|PDB:2VR2}.
FT   HELIX       355    363       {ECO:0000244|PDB:2VR2}.
FT   TURN        364    367       {ECO:0000244|PDB:2VR2}.
FT   HELIX       371    378       {ECO:0000244|PDB:2VR2}.
FT   HELIX       380    385       {ECO:0000244|PDB:2VR2}.
FT   TURN        389    391       {ECO:0000244|PDB:2VR2}.
FT   STRAND      403    413       {ECO:0000244|PDB:2VR2}.
FT   TURN        416    418       {ECO:0000244|PDB:2VR2}.
FT   STRAND      420    422       {ECO:0000244|PDB:2VR2}.
FT   TURN        427    430       {ECO:0000244|PDB:2VR2}.
FT   STRAND      432    442       {ECO:0000244|PDB:2VR2}.
FT   STRAND      445    449       {ECO:0000244|PDB:2VR2}.
FT   HELIX       470    482       {ECO:0000244|PDB:2VR2}.
SQ   SEQUENCE   519 AA;  56630 MW;  882E33D7C49D6ECC CRC64;
     MAAPSRLLIR GGRVVNDDFS EVADVLVEDG VVRALGHDLL PPGGAPAGLR VLDAAGKLVL
     PGGIDTHTHM QFPFMGSRSI DDFHQGTKAA LSGGTTMIID FAIPQKGGSL IEAFETWRSW
     ADPKVCCDYS LHVAVTWWSD QVKEEMKILV QDKGVNSFKM FMAYKDLYMV TDLELYEAFS
     RCKEIGAIAQ VHAENGDLIA EGAKKMLALG ITGPEGHELC RPEAVEAEAT LRAITIASAV
     NCPLYIVHVM SKSAAKVIAD ARRDGKVVYG EPIAASLGTD GTHYWNKEWH HAAHHVMGPP
     LRPDPSTPDF LMNLLANDDL TTTGTDNCTF NTCQKALGKD DFTKIPNGVN GVEDRMSVIW
     EKGVHSGKMD ENRFVAVTST NAAKIFNLYP RKGRIAVGSD ADIVIWDPKG TRTISAKTHH
     QAVNFNIFEG MVCHGVPLVT ISRGKVVYEA GVFSVTAGDG KFIPRKPFAE YIYKRIKQRD
     RTCTPTPVER APYKGEVATL KSRVTKEDAT AGTRKQAHP
//
